Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U1SI
|
||||
Former ID |
DIB017008
|
||||
Drug Name |
Bimoclomol
|
||||
Synonyms |
ABT-822; BRLP-42; BRX-211
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Discontinued in Phase 2 | [545697] | ||
Company |
CytRx; Biorex Research and Development Co
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H20ClN3O2
|
||||
Canonical SMILES |
C(=N\OCC(CN1CCCCC1)O)(/c1cnccc1)\Cl
|
||||
CAS Number |
CAS 130493-03-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Heat shock protein 70 | Target Info | Modulator | [526247] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.